Eli Lilly’s Orfoscerinib: Jefferies Raises Price Target
Investment banking firm Jefferies raises Eli Lilly's price target based on optimism over orfoscerinib, indicating strong confidence in its potential. ...
- Latest
- Trending
Investment banking firm Jefferies raises Eli Lilly's price target based on optimism over orfoscerinib, indicating strong confidence in its potential. ...
Technology is crucial for treasurers and their partners, enhancing decision-making and operational efficiency. J.P. Morgan Payments offers customized solutions and ...
Retik Finance, a new cryptocurrency priced at $0.11, has caught the attention of top Solana and Ethereum investors. With innovative ...
ANZ Group, Australia's fourth-largest bank, plans to cut 170 jobs as it automates operations, leading to concerns about employee morale ...
Asian shares mostly rise as investors monitor U.S. inflation. Japan's Nikkei 225 surges 2.2%, Australia's S&P/ASX 200 increases 0.1%, and ...
Butterfield Bank reports strong financial results for 2023, including a net income of $225.5 million. The bank also declares a ...
Berkshire Hills Bancorp has announced the date for its 2024 Annual Meeting of Shareholders, where important agenda items will be ...
Discover Financial Services CFO John Greene will be presenting at the Global Financial Institutions Conference, offering insights into the company's ...
IT contractor CGI Federal has reported a data breach that exposed personal information of about 6,000 employees, causing potential financial ...
The banking crisis of March 2023 raises concerns about the stability of the US banking system. Several mid-sized banks failed, ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.